Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Healthcare Realty Trust Incorporated Common Stock (HR) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Healthcare Realty Trust Incorporated Common StockTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Healthcare Realty Trust Incorporated Common Stock vs State Street SPDR S&P Biotech ETF — how do they compare? Healthcare Realty Trust Incorporated Common Stock trades at $17 (market cap $5.84B), while State Street SPDR S&P Biotech ETF trades at $147.2 (market cap $10.05B). The key difference: State Street SPDR S&P Biotech ETF is the larger of the two by market cap, and Healthcare Realty Trust Incorporated Common Stock pays a 5.63% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Healthcare Realty Trust Incorporated Common Stock for 0 Days and State Street SPDR S&P Biotech ETF for 39 Days on average.

HRXBI
Market Cap
$5.84B$10.05B
Volume
5,755,90710,367,649
Sector
Real EstateBroad Market / Factor
52-Week High
$21.87$169.55
52-Week Low
$16.34$107.32
Typical Hold Time
0 Days39 Days
Enterprise Value
$10.22B—
Dividend Yield
5.63%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Healthcare Realty Trust Incorporated Common Stock

No Aura AI signal available yet.

State Street SPDR S&P Biotech ETF

XBI trades at $146.8, down 3.04% today amid a bearish technical signal. The ETF's modified equal-weight structure provides exposure to over 150 biotech names, benefiting from M&A activity and positive clinical catalysts. Recent news highlights a 76% prior-year rally and optimism around cancer vaccine breakthroughs from Merck and Moderna. However, the ETF carries higher volatility and expense ratios compared to broader healthcare funds.

Outlook remains mixed with technical indicators bearish but fundamental catalysts present. Investment opportunity lies in targeted biotech exposure and sector innovation, though risks include high volatility, regulatory uncertainty, and reliance on clinical trial successes. Analyst consensus is neutral with 100% hold rating, suggesting cautious optimism amid recent price declines.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HR
100% Buy0% Sell
Avg holding period · 0 Days
XBI
100% Buy0% Sell
Avg holding period · 39 Days

About Healthcare Realty Trust Incorporated Common Stock

Healthcare Realty Trust Incorporated is a real estate investment trust that owns and manages outpatient medical facilities and on-campus medical office buildings across US, leasing space to physician groups, hospitals, and health systems.

Read more on HR →

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI →